- Home
- ASGN vs FOLD Comparison
ASGN vs FOLD Comparison
Compare ASGN & FOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASGN
- FOLD
- Stock Information
- Founded
- ASGN 1985
- FOLD 2002
- Country
- ASGN United States
- FOLD United States
- Employees
- ASGN N/A
- FOLD N/A
- Industry
- ASGN Professional Services
- FOLD Biotechnology: Pharmaceutical Preparations
- Sector
- ASGN Consumer Discretionary
- FOLD Health Care
- Exchange
- ASGN Nasdaq
- FOLD Nasdaq
- Market Cap
- ASGN 2.6B
- FOLD 2.9B
- IPO Year
- ASGN 1992
- FOLD 2007
- Fundamental
- Price
- ASGN $58.23
- FOLD $6.83
- Analyst Decision
- ASGN Buy
- FOLD Strong Buy
- Analyst Count
- ASGN 5
- FOLD 9
- Target Price
- ASGN $96.40
- FOLD $17.00
- AVG Volume (30 Days)
- ASGN 525.2K
- FOLD 3.9M
- Earning Date
- ASGN 04-23-2025
- FOLD 05-08-2025
- Dividend Yield
- ASGN N/A
- FOLD N/A
- EPS Growth
- ASGN N/A
- FOLD N/A
- EPS
- ASGN 3.83
- FOLD N/A
- Revenue
- ASGN $4,099,700,000.00
- FOLD $528,294,999.00
- Revenue This Year
- ASGN $1.37
- FOLD $21.83
- Revenue Next Year
- ASGN $6.06
- FOLD $22.16
- P/E Ratio
- ASGN $15.19
- FOLD N/A
- Revenue Growth
- ASGN N/A
- FOLD 32.29
- 52 Week Low
- ASGN $55.95
- FOLD $6.20
- 52 Week High
- ASGN $105.67
- FOLD $12.65
- Technical
- Relative Strength Index (RSI)
- ASGN 35.29
- FOLD 32.01
- Support Level
- ASGN $55.95
- FOLD $6.20
- Resistance Level
- ASGN $60.96
- FOLD $6.95
- Average True Range (ATR)
- ASGN 2.71
- FOLD 0.43
- MACD
- ASGN 0.16
- FOLD -0.04
- Stochastic Oscillator
- ASGN 27.34
- FOLD 29.86
About ASGN ASGN Incorporated
ASGN Inc is a provider of information technology (IT) services and professional solutions, including technology, creative, and digital, across the commercial and government sectors. It operates through two segments, Commercial and Federal Government. The Commercial Segment, which generates the majority of the revenue, provides consulting, creative digital marketing, and permanent placement services to Fortune 1000 clients and mid-market companies. The Federal Government Segment provides mission-critical solutions to the Department of Defense, intelligence agencies, and civilian agencies.
About FOLD Amicus Therapeutics Inc.
Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.